[go: up one dir, main page]

IS4974A - Lyfjasamsetning á þrýstingsúðaformi - Google Patents

Lyfjasamsetning á þrýstingsúðaformi

Info

Publication number
IS4974A
IS4974A IS4974A IS4974A IS4974A IS 4974 A IS4974 A IS 4974A IS 4974 A IS4974 A IS 4974A IS 4974 A IS4974 A IS 4974A IS 4974 A IS4974 A IS 4974A
Authority
IS
Iceland
Prior art keywords
pressure
pharmaceutical composition
spray pharmaceutical
spray
composition
Prior art date
Application number
IS4974A
Other languages
English (en)
Other versions
IS2435B (is
Inventor
Lewis David
Ganderton Davis
Meakin Brian
Ventura Paolo
Brambilla Gaetano
Garzia Raffaella
Original Assignee
Chiesi Farmaceutici S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10814179&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IS4974(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Chiesi Farmaceutici S.P.A. filed Critical Chiesi Farmaceutici S.P.A.
Publication of IS4974A publication Critical patent/IS4974A/is
Publication of IS2435B publication Critical patent/IS2435B/is

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dispersion Chemistry (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IS4974A 1997-06-13 1999-02-11 Lyfjafræðileg loftúðasamsetning IS2435B (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9712434A GB2326334A (en) 1997-06-13 1997-06-13 Pharmaceutical aerosol compositions
PCT/EP1998/003533 WO1998056349A1 (en) 1997-06-13 1998-06-10 Pharmaceutical aerosol composition

Publications (2)

Publication Number Publication Date
IS4974A true IS4974A (is) 1999-02-11
IS2435B IS2435B (is) 2008-10-15

Family

ID=10814179

Family Applications (1)

Application Number Title Priority Date Filing Date
IS4974A IS2435B (is) 1997-06-13 1999-02-11 Lyfjafræðileg loftúðasamsetning

Country Status (44)

Country Link
EP (2) EP1219293A3 (is)
JP (1) JP4380802B2 (is)
KR (1) KR100546239B1 (is)
CN (1) CN1138532C (is)
AR (1) AR012977A1 (is)
AT (1) ATE222751T1 (is)
AU (1) AU729966B2 (is)
BG (1) BG63906B1 (is)
BR (1) BR9805993B1 (is)
CA (1) CA2263445C (is)
CO (1) CO4940408A1 (is)
CZ (1) CZ295521B6 (is)
DE (1) DE69807420T3 (is)
DK (1) DK0920302T4 (is)
DZ (1) DZ2516A1 (is)
EA (1) EA001259B1 (is)
EE (1) EE03664B1 (is)
ES (1) ES2182351T5 (is)
GB (1) GB2326334A (is)
GE (1) GEP20012462B (is)
HR (1) HRP980317B1 (is)
HU (1) HU228487B1 (is)
ID (1) ID21491A (is)
IL (1) IL128484A (is)
IN (1) IN189317B (is)
IS (1) IS2435B (is)
IT (1) IT1293803B1 (is)
MA (1) MA26507A1 (is)
ME (2) MEP44008A (is)
MY (1) MY119074A (is)
NO (1) NO327775B1 (is)
NZ (1) NZ334149A (is)
PL (1) PL193721B1 (is)
PT (1) PT920302E (is)
RS (1) RS51274B (is)
SA (1) SA98190821B1 (is)
SI (1) SI0920302T2 (is)
SK (1) SK284430B6 (is)
TN (1) TNSN98087A1 (is)
TR (1) TR199900288T1 (is)
TW (1) TW555570B (is)
UA (1) UA70289C2 (is)
WO (1) WO1998056349A1 (is)
ZA (1) ZA985136B (is)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9616237D0 (en) 1996-08-01 1996-09-11 Norton Healthcare Ltd Aerosol formulations
US20010031244A1 (en) 1997-06-13 2001-10-18 Chiesi Farmaceutici S.P.A. Pharmaceutical aerosol composition
IT1303788B1 (it) * 1998-11-25 2001-02-23 Chiesi Farma Spa Formulazioni di aerosol medicinali.
DZ2947A1 (fr) * 1998-11-25 2004-03-15 Chiesi Farma Spa Inhalateur à compteur de dose sous pression.
IT1313553B1 (it) 1999-07-23 2002-09-09 Chiesi Farma Spa Formulazioni ottimizzate costituite da soluzioni di steroidi dasomministrare per inalazione.
IT1317904B1 (it) 1999-09-11 2003-07-15 Glaxo Group Ltd Formulazione farmaceutica di propionato di fluticasone.
DE60017450T2 (de) * 1999-11-23 2006-03-02 Glaxo Group Ltd., Greenford Pharmazeutische formulierungen enthaltend salmeterol
DE60019167T2 (de) * 1999-12-24 2006-05-11 Glaxo Group Ltd., Greenford Pharmazeutische aerosol formulierung enthaltend salmeterol und fluticason
IT1317846B1 (it) 2000-02-22 2003-07-15 Chiesi Farma Spa Formulazioni contenenti un farmaco anticolinergico per il trattamentodella broncopneumopatia cronica ostruttiva.
IT1318514B1 (it) * 2000-05-12 2003-08-27 Chiesi Farma Spa Formulazioni contenenti un farmaco glucocorticosteroide per iltrattamento di patologie broncopolmonari.
UA73986C2 (uk) * 2000-05-22 2005-10-17 К'Єзі Фармачеутічі С.П.А. АЕРОЗОЛЬНА КОМПОЗИЦІЯ, ЩО МІСТИТЬ <font face="Symbol">b</font>2-АДРЕНЕРГІЧНИЙ АГОНІСТ ТРИВАЛОЇ ДІЇ, ДОЗУЮЧИЙ ІНГАЛЯТОР ПІД ТИСКОМ ТА СПОСІБ ЙОГО ЗАПОВНЕННЯ
AU2002238748A1 (en) * 2001-03-12 2002-09-24 Glaxo Group Limited Pharmaceutical aerosol formulation
DE60103527T2 (de) 2001-07-02 2005-06-16 Chiesi Farmaceutici S.P.A. Optimierte Tobramycin-Formulierung zur Aerosolbildung
EP1340503A1 (en) * 2002-03-01 2003-09-03 CHIESI FARMACEUTICI S.p.A. Solution aerosol formulation containing esters of 3, 17-dihydroxy oestratriene derivates for pulmonary delivery
EP1340492A1 (en) * 2002-03-01 2003-09-03 CHIESI FARMACEUTICI S.p.A. Aerosol formulations for pulmonary administration of medicaments having systemic effects
ATE465712T1 (de) 2002-03-01 2010-05-15 Chiesi Farma Spa Ultrafeine zusammensetzungen von formoterol
DE10214263A1 (de) * 2002-03-28 2003-10-16 Boehringer Ingelheim Pharma HFA-Suspensionsformulierungen enthaltend ein Anticholinergikum
EP1369113B1 (en) * 2002-06-06 2006-11-22 CHIESI FARMACEUTICI S.p.A. Solubilisation of drugs in HFA propellant by means of emulsions
AU2003293528A1 (en) * 2003-02-04 2004-09-06 Chrysalis Technologies Incorporated Perfluorocarbon and hydrofluorocarbon formulations and methods of making and using same
EP1915985A1 (en) 2003-03-20 2008-04-30 Boehringer Ingelheim Pharmaceuticals Inc. Formulation for a Metered Dose Inhaler Using Hydro-Fluoro-Alkanes as Propellants
AU2004224367B2 (en) * 2003-03-20 2009-10-08 Boehringer Ingelheim Pharmaceuticals, Inc. Formulation for a metered dose inhaler using hydro-fluoro-alkanes as propellants
SE0303179D0 (sv) * 2003-11-26 2003-11-26 Astrazeneca Ab Novel compounds
EP1595531A1 (en) 2004-05-13 2005-11-16 CHIESI FARMACEUTICI S.p.A. Stable pharmaceutical solution formulations for pressurized metered dose inhalers
WO2006002840A2 (de) 2004-07-02 2006-01-12 Boehringer Ingelheim International Gmbh Aerosolsuspensionsformulierungen mit tg 227 ea oder tg 134 a als treibmittel
DE102006017320A1 (de) 2006-04-11 2007-10-18 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosolsuspensionsformulierungen mit TG 227 ea oder TG 134 a als Treibmittel
GB0621707D0 (en) 2006-10-31 2006-12-13 Univ London Pharmacy Formulations for delivery via pressurised metered dose inhalers
GB0712454D0 (en) 2007-06-27 2007-08-08 Generics Uk Ltd Pharmaceutical compositions
CN101909652A (zh) * 2007-11-07 2010-12-08 阿斯利康(瑞典)有限公司 含有抗坏血酸衍生物的干粉制剂
BR112013005284A2 (pt) * 2010-09-06 2019-09-24 Chiesi Farm Spa inalador dosimetrado e uso de um inalador dosimetrado
JP5409594B2 (ja) * 2010-12-22 2014-02-05 キエシ・フアルマチエウテイチ・ソチエタ・ペル・アチオニ 加圧式定量吸入器のための安定な製薬学的溶液製剤
WO2013127738A1 (de) 2012-02-28 2013-09-06 Boehringer Ingelheim International Gmbh Neue treibgashaltige tiotropium-formulierung
RU2504402C1 (ru) * 2012-11-20 2014-01-20 Шолекс Девелопмент Гмбх Ингаляционный состав в форме аэрозоля для лечения бронхиальной астмы и хронической обструктивной болезни легких
GB201402513D0 (en) 2014-02-13 2014-04-02 Cardiff Scintigraphics Ltd Pressurised metered dose inhalers and method of manufacture
EP3174522A1 (en) 2014-07-29 2017-06-07 3M Innovative Properties Company Method of preparing a pharmaceutical composition
MA43782A (fr) 2016-03-31 2021-04-28 Chiesi Farm Spa Dispositif d'inhalation d'aérosol
CN113069417A (zh) * 2016-09-19 2021-07-06 墨西哥氟石股份公司 药物组合物
WO2025039045A1 (en) * 2023-08-23 2025-02-27 Inhaler Supplies Pty Ltd Inhalable formulation for volatile actives

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT84439B (pt) † 1986-03-10 1989-10-04 Burghart Kurt Processo de preparacao de composicoes farmaceuticas a base de nifedipina
WO1987005210A1 (fr) † 1986-03-10 1987-09-11 Kurt Burghart Produit pharmaceutique et son procede de preparation
US4899874A (en) † 1988-04-26 1990-02-13 Rehrig-Pacific Company, Inc. Stackable low depth bottle case
GB8828477D0 (en) * 1988-12-06 1989-01-05 Riker Laboratories Inc Medical aerosol formulations
US5225183A (en) † 1988-12-06 1993-07-06 Riker Laboratories, Inc. Medicinal aerosol formulations
DE3905726A1 (de) * 1989-02-24 1990-08-30 Hoechst Ag Druckgaspackung und treibmittel fuer aerosole
ATE114112T1 (de) † 1990-10-18 1994-12-15 Minnesota Mining & Mfg Aerosolzubereitung, die beclometason 17,21- dipropionat enthält.
GB9024365D0 (en) * 1990-11-09 1991-01-02 Glaxo Group Ltd Medicaments
EP0504112A3 (en) * 1991-03-14 1993-04-21 Ciba-Geigy Ag Pharmaceutical aerosol formulations
YU59192A (sh) * 1991-06-10 1994-12-28 Schering Corporation Formulacija aerosola koje ne sadrže hlorofluorougljenična jedinjenja
SK140493A3 (en) † 1991-06-10 1994-10-05 Schering Corp Non-chlorofluorocarbon aerosol formulations
DE4123668A1 (de) * 1991-07-17 1993-01-21 Rovema Gmbh Verfahren und vorrichtung zur zufuehrung von folienmaterial zu einer intermittierend arbeitenden schlauchbeutelmaschine
DE4123663A1 (de) * 1991-07-17 1993-01-21 Schwabe Willmar Gmbh & Co Aerosol-zubereitung und verwendung eines treibmittels dafuer
ATE128350T1 (de) * 1991-12-12 1995-10-15 Glaxo Group Ltd Pharmazeutische aerosolformulierung.
EP1086688B1 (en) * 1991-12-18 2004-03-03 Minnesota Mining And Manufacturing Company Suspension aerosol formulations
DE69324161T2 (de) * 1992-12-09 1999-10-28 Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield Stabilisierte medizinische aerosollösungen
US5502076A (en) * 1994-03-08 1996-03-26 Hoffmann-La Roche Inc. Dispersing agents for use with hydrofluoroalkane propellants
US5508023A (en) * 1994-04-11 1996-04-16 The Center For Innovative Technology Pharmaceutically acceptable agents for solubilizing, wetting, emulsifying, or lubricating in metered dose inhaler formulations which use HFC-227 propellant
US5534242A (en) † 1994-05-02 1996-07-09 Henry; Richard A. Lidocaine-vasoconstrictor aerosol preparation
JP3911290B2 (ja) † 1994-05-13 2007-05-09 アラダイム コーポレーション エアゾールを含む麻酔用処方
US5653961A (en) † 1995-03-31 1997-08-05 Minnesota Mining And Manufacturing Company Butixocort aerosol formulations in hydrofluorocarbon propellant
US5635161A (en) † 1995-06-07 1997-06-03 Abbott Laboratories Aerosol drug formulations containing vegetable oils
GB9517998D0 (en) † 1995-09-04 1995-11-08 Bioglan Lab Ltd Compositions and device for their administration
EP0914143A1 (en) * 1996-07-08 1999-05-12 Rhone-Poulenc Rorer Limited Medicinal cyclosporin-a aerosol solution formulation
DE69734017T2 (de) † 1996-12-04 2006-06-14 Link Products Ltd Arzneimittelzusammensetzungen und vorrichtungen zu deren verabreichung
JP2001511160A (ja) † 1997-02-05 2001-08-07 ヤゴ リサーチ アクチェンゲゼルシャフト 医学用エアゾール配合物

Also Published As

Publication number Publication date
UA70289C2 (uk) 2004-10-15
JP4380802B2 (ja) 2009-12-09
NO327775B1 (no) 2009-09-21
EP0920302A1 (en) 1999-06-09
TW555570B (en) 2003-10-01
CO4940408A1 (es) 2000-07-24
ES2182351T3 (es) 2003-03-01
WO1998056349A1 (en) 1998-12-17
NO990594L (no) 1999-04-13
ITMI971798A1 (it) 1999-01-28
ZA985136B (en) 1999-01-07
DK0920302T3 (da) 2002-12-23
DE69807420T2 (de) 2003-05-08
DZ2516A1 (fr) 2004-11-08
EE9900055A (et) 1999-08-16
HRP980317A2 (en) 1999-04-30
HK1022271A1 (en) 2000-08-04
EP1219293A2 (en) 2002-07-03
EE03664B1 (et) 2002-04-15
ATE222751T1 (de) 2002-09-15
CA2263445A1 (en) 1998-12-17
KR100546239B1 (ko) 2006-01-26
BG63906B1 (bg) 2003-06-30
SI0920302T2 (sl) 2006-10-31
IN189317B (is) 2003-02-08
HUP0001339A2 (hu) 2000-09-28
ES2182351T5 (es) 2007-03-16
DK0920302T4 (da) 2006-10-09
RS51274B (sr) 2010-12-31
KR20000068171A (ko) 2000-11-25
IL128484A (en) 2004-09-27
EP1219293A3 (en) 2003-05-28
EA001259B1 (ru) 2000-12-25
NZ334149A (en) 2000-07-28
SK17699A3 (en) 1999-07-12
MY119074A (en) 2005-03-31
IT1293803B1 (it) 1999-03-10
YU6999A (sh) 2000-03-21
HUP0001339A3 (en) 2000-10-30
DE69807420D1 (de) 2002-10-02
BR9805993B1 (pt) 2009-05-05
CZ46299A3 (cs) 1999-07-14
AR012977A1 (es) 2000-11-22
TR199900288T1 (xx) 1999-09-21
HRP980317B1 (en) 2002-06-30
EP0920302B1 (en) 2002-08-28
SK284430B6 (sk) 2005-04-01
PL193721B1 (pl) 2007-03-30
NO990594D0 (no) 1999-02-09
CN1138532C (zh) 2004-02-18
CN1229355A (zh) 1999-09-22
IS2435B (is) 2008-10-15
ID21491A (id) 1999-06-17
MEP44008A (en) 2011-02-10
IL128484A0 (en) 2000-01-31
SA98190821B1 (ar) 2006-11-19
GB2326334A (en) 1998-12-23
JP2000516965A (ja) 2000-12-19
AU8626298A (en) 1998-12-30
SI0920302T1 (en) 2002-12-31
BR9805993A (pt) 1999-08-31
TNSN98087A1 (fr) 2005-03-15
GEP20012462B (en) 2001-06-25
PL331531A1 (en) 1999-07-19
CZ295521B6 (cs) 2005-08-17
DE69807420T3 (de) 2006-11-16
CA2263445C (en) 2008-09-09
PT920302E (pt) 2002-11-29
EP0920302B2 (en) 2006-06-21
AU729966B2 (en) 2001-02-15
BG103221A (en) 1999-09-30
EA199900201A1 (ru) 1999-06-24
MA26507A1 (fr) 2004-12-20
ME00333B (me) 2011-02-10
HU228487B1 (en) 2013-03-28
GB9712434D0 (en) 1997-08-13

Similar Documents

Publication Publication Date Title
IS4974A (is) Lyfjasamsetning á þrýstingsúðaformi
ID22891A (id) Komposisi farmasi untuk kombinasi piperidinoalkanol-dekongestan
ID23874A (id) Obat
ID27415A (id) Komposisi farmaseutik
ID24654A (id) Formulasi farmasi omeprazola
NO980546D0 (no) Farmasöytiske midler
ID25508A (id) Komposisi dematologis
ID29262A (id) Komposisi farmasi
ID27201A (id) Komposisi farmasi
NO984771D0 (no) F°lgesystem
DK1017392T3 (da) Lægemiddel
ID27150A (id) Sediaan levotiroksin bahan farmasi
IS5331A (is) Ný lyfjablanda
ID23250A (id) Komposisi paroksetin
EE9900545A (et) Farmatseutiline kompositsioon
ID21906A (id) Komposisi adesif
ID29294A (id) Komposisi farmasi
BR9507768A (pt) Composição farmacêutica
MA26531A1 (fr) Composition pharmaceutique
ID18698A (id) Komposisi farmasi
ID25857A (id) Komposisi farmasi
ID26215A (id) Komposisi farmasi
FI961364L (fi) Lääkeainekoostumus
ITMI962628A0 (it) Composizione farmaceutica
ID23531A (id) Komposisi farmasi